Severely Ill COVID-19 patient at Southern California medical center extubated three days after treatment with CytoDyn’s leronlimab
On Apr. 9, 2020, CytoDyn announced a patient with severe COVID-19 under the care of a leading medical…
-
-
NIH began clinical trial of hydroxychloroquine as potential therapy for COVID-19
On Apr. 9, 2020, the first participants were enrolled in the trial at Vanderbilt University Medical Center, Nashville,…
-
Biotechnology | COVID-19 | Infectious Disease | Influenza | Medicine | Pharmaceutical | Therapeutics
Fujifilm announced the start of a phase II clinical trial of its influenza antiviral drug ‘Avigan’ Tablet for COVID-19 patients in the U.S.
On Apr. 9, 2020, FUJIFILM announced initiation of a U.S. phase II clinical trial to evaluate the safety…
-
Laurent Pharmaceuticals joined battle against COVID-19
On Apr. 9, 2020, Laurent Pharmaceuticals announced that a spin off from McGill University planned to test its…
-
Positive data generated by Biosig subsidiary ViralClear on Covid-19 Coronavirus published in bioRxiv
On Apr. 9, 2020, BioSig Technologies announced that an article titled “The IMPDH inhibitor merimepodib suppresses SARS-COV-2 replications”…
-
Washington University launched Clinical trial to evaluate COVID-19 treatment
On Apr. 9, 2020, Washington University School of Medicine in St. Louis launched a clinical trial for patients…
-
LabCorp and Ciox Health announced an agreement to create a comprehensive COVID-19 patient data registry
On Apr. 9, 2020, LabCorp and Ciox Health announced an agreement to collaborate on a comprehensive U.S.-based COVID-19…
-
BioCryst began clinical trial with Galidesivir for treatment of patients with COVID-19
On Apr. 9, 2020, BioCryst Pharmaceuticals announced the company has opened enrollment into a randomized, double-blind, placebo-controlled clinical…
-
Nanomix awarded BARDA contract for development of rapid, mobile, point-of-care assays to detect COVID-19
On Apr. 8, 2020, Nanomix announced that the company had been awarded $570,000 in funding from Biomedical Advanced…
-
Novavax identified Coronavirus vaccine candidate; accelerated initiation of first-in-human trial to mid-May
On Apr. 8, 2020, Novavax announced it had identified a coronavirus vaccine candidate, NVX-CoV2373, a stable, prefusion protein…
-
Chugai started phase III clinical trial of Actemra for COVID-19 pneumonia in Japan
On Apr. 8, 2020, Chugai Pharma announced that it is working to start a phase III clinical trial…
-
Arizona COVID-19 Genomics Union to track the virus
On Apr. 8, 2020, TGen, an affiliate of City of Hope, The Pathogen and Microbiome Institute at Northern…
-
Mateon expanded its COVID-19 therapeutic program to include Artemisinin
On Apr. 8, 2020, Mateon Therapeutics announced that its COVID-19 directed antiviral screening program discovered that Artemisinin is…
-
MediciNova announced plans to initiate a clinical trial of MN-166 (ibudilast) for COVID-19 Acute Respiratory Distress Syndrome
On Apr. 8, 2020, MediciNova announced that it had initiated a clinical trial of MN-166 (ibudilast) for acute…
-
Karyopharm to evaluate low dose Selinexor as potential treatment for hospitalized patients with COVID-19
On Apr. 7, 2020, Karyopharm Therapeutics announced plans to initiate a global randomized clinical trial for low dose…
-
Cumberland Pharma expanded availability of Vaprisol to treat Hyponatremia for critical care COVID-19 patients
On Apr. 7, 2020, Cumberland Pharma announced an initiative to increase availability of Vaprisol (conivaptan hydrochloride) injection for…
-
Mesa Biotech to ship 10,000 Accula SARS-CoV-2 tests for 30 minute rapid molecular point of care diagnosis
On Apr. 7, 2020, Mesa Biotech announced it was shipping 10,000 of its Accula SARS-CoV-2 molecular rapid point…
-
FDA approved Emory University human clinical trials for Emory COVID-19 antiviral
On Apr. 7, 2020, the U.S. Food and Drug Administration (FDA) approved an Investigational New Drug application by…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
Rice University established COVID-19 research fund
On Apr. 6, 2020, Rice University announced it had established a research accelerator fund to support projects –…
-
FDA cleared Mesoblast IND for remestemcel use in COVID-19 ARDS patients
On Apr. 6, 2020, Mesoblast announced it had received clearance from the U.S. Food and Drug Administration (FDA)…
-
Mateon achieved milestone in development of OT-101, a phase 3 clinical drug candidate, against COVID-19
On Apr. 6, 2020, Mateon Therapeutics announced that it has delivered the requisite testing results to Golden Mountain…
-
New antiviral drug from Emory University heading into clinical trials for COVID-19 treatment
On Apr. 6, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced its participation in a clinical trial…
-
3M and White House announced plan to import 166.5 million additional respirators into the U.S. over the next three months
On Apr. 6, 2020, 3M and the White House announced a plan to import 166.5 million respirators over…
-
Seattle area philanthropists responded to COVID-19 care and research needs
On Apr. 6, 2020, the University of Washington Medicine (UW) announced that more than $20 million has been…
-
INOVIO initiated phase 1 clinical trial of its COVID-19 vaccine
On Apr. 6, 2020, Inovio Pharma announced the U.S. Food and Drug Administration (FDA) had accepted the company’s…
-
OraSure Technologies received BARDA contract for Rapid Oral Fluid Pan-SARS-Coronavirus in-home self-test
On Apr. 6, 2020, OraSure Technologies announced it had been awarded a $710,310 contract from the Biomedical Advanced…
-
Luminex received FDA Emergency Use Authorization for ARIES SARS-CoV-2 assay to detect virus responsible for COVID-19 disease
On Apr. 6, 2020, Luminex announced announced that the FDA has issued an Emergency Use Authorization for its…
-
VGXI supported rapid timeline to clinical testing for Coronavirus vaccine
On Apr. 6, 2020, VGXI, announced it had completed manufacturing and release of a DNA vaccine to combat…
-
VGXI established pilot mRNA manufacturing capabilities
On Apr. 6, 2020, VGX announced successful implementation of new RNA production services through completion of all Phase…
-
Minneapolis Heart Institute Foundation engaged in COVID-19 STEMI research study
On Apr. 6, 2020, the Minneapolis Heart Institute Foundation (MHIF) announced it was serving as the international coordinating…
